We performed a survey, based on a questionnaire including 20 items, submitted anonymously to Italian trainees in Allergology and Clinical Immunology, in order to obtain information about their specific allergen immunotherapy (AIT) practices. The questionnaire was sent to 40 trainees, who had attended the last two years of the training course. Thirty-four subjects (mean age: 27 years, 65% females) adequately completed thesur vey. Theans wers to theque stionnaireshow ed that only 60% of thet raining programs included lectures on AIT. Among the trainees using AIT, only 40% declared being able to prescribe it independently, while 60% were guided by a tutor. Of the trainees who wereab le to prescribeAI T autonomously, 60% werefami liar with both routes of administration, i.e. subcutaneous (SCIT) and sublingual immunotherapy (SLIT), while2 5% of theseuse d only SLIT. In 80% of thet raining institutions involved, the trainees could attend a dedicated AIT outpatient ward for SCIT administration; only 40% administered AIT personally, and in half of these cases, they were guided by a tutor. Only 70% of trainees had experience in the follow-up of patients still under treatment and of patients who had completed treatment. Analysis of the answers obtained for questions on venom immunotherapy (VIT) showed that, in 90% of cases, the trainees attended a dedicated outpatients ward where VIT is administered, but with a role limited to observation/cooperation. Only 30% were involved in the followup of patients who were under treatment or who had completed VIT. Only 20% of the trainees felt confident enough about VIT to prescribe this treatment independently, 80% knew there were several administration protocols, and the majority prescribed products from three different manufacturers. These findings suggest that there is significant room for improving theinst ructions provided regarding allergology and clinical immunology to trainees in Italy with respect to AIT.
Allergen immunotherapy: clinical and practical education of Italian trainees in allergy and clinical immunology schools / Ridolo, Erminia; C., Incorvaia; Senna, G. E.; M., Montagni; E., Olivieri; Canonica, G. W.. - In: EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY. - ISSN 1764-1489. - 45:(2013), pp. 49-52.
Allergen immunotherapy: clinical and practical education of Italian trainees in allergy and clinical immunology schools
RIDOLO, Erminia;
2013-01-01
Abstract
We performed a survey, based on a questionnaire including 20 items, submitted anonymously to Italian trainees in Allergology and Clinical Immunology, in order to obtain information about their specific allergen immunotherapy (AIT) practices. The questionnaire was sent to 40 trainees, who had attended the last two years of the training course. Thirty-four subjects (mean age: 27 years, 65% females) adequately completed thesur vey. Theans wers to theque stionnaireshow ed that only 60% of thet raining programs included lectures on AIT. Among the trainees using AIT, only 40% declared being able to prescribe it independently, while 60% were guided by a tutor. Of the trainees who wereab le to prescribeAI T autonomously, 60% werefami liar with both routes of administration, i.e. subcutaneous (SCIT) and sublingual immunotherapy (SLIT), while2 5% of theseuse d only SLIT. In 80% of thet raining institutions involved, the trainees could attend a dedicated AIT outpatient ward for SCIT administration; only 40% administered AIT personally, and in half of these cases, they were guided by a tutor. Only 70% of trainees had experience in the follow-up of patients still under treatment and of patients who had completed treatment. Analysis of the answers obtained for questions on venom immunotherapy (VIT) showed that, in 90% of cases, the trainees attended a dedicated outpatients ward where VIT is administered, but with a role limited to observation/cooperation. Only 30% were involved in the followup of patients who were under treatment or who had completed VIT. Only 20% of the trainees felt confident enough about VIT to prescribe this treatment independently, 80% knew there were several administration protocols, and the majority prescribed products from three different manufacturers. These findings suggest that there is significant room for improving theinst ructions provided regarding allergology and clinical immunology to trainees in Italy with respect to AIT.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
